Avalanche Biotechnologies, Inc. (symbol: AAVL) is on a winning streak, it
has risen in 9 out of the last 10 trading days as of 2016-02-22. The
average dialy change was 2.928%. In terms of volume of shares changing
hands, it averaged 573,900 vs. the usual 366,833
The closing price was $5.51, amounting to a market cap of $117,690,000. The
stock has been trading at a range between $4.0 and $45.18.
AAVL is in the Biotechnology: Biological Products (No Diagnostic
Substances) industry. Analyst expect it to earn $-1.67 per share this year,
and $-1.39 next year. The 1-year target price is expected to be $14.83
No comments:
Post a Comment